Gts Securities LLC Novartis Ag Put Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $1.81 Million - $2.07 Million	17,100 Added 53.61%	49,000 $5.64 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $722,046 - $837,486	7,800 Added 32.37%	31,900 $3.4 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $4.73 Million - $5.39 Million	-49,700 Reduced 67.34%	24,100 $2.33 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $2.6 Million - $2.86 Million	-28,200 Reduced 27.65%	73,800 $7.45 Million
Q3 2023 Nov 15, 2023	BUY	$94.73 - $105.13 $9.66 Million - $10.7 Million	102,000 New	102,000 $10.4 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $208B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.